Ajinomoto acquires Althea TechnologiesIllustrative image – not actual.

Ajinomoto Co., Inc. has acquired Althea Technologies Inc., a US-based biopharmaceutical CDMO.


As per acquisition valued US $ 175 million (approx Rs 959 crore), Althea is now a fully consolidated subsidiary of Ajinomoto Co. under the new name Ajinomoto Althea Inc. Ajinomoto is planning to to expand the business for contract biopharmaceutical development and manufacturing services in the North American market, and to strengthen the Ajinomoto Group’s advanced biomedical business.
 


 

← All latest storiesBack to top →